MODULATING CELLULAR SENESCENCE AND MTOR PATHWAY: THE THERAPEUTIC POTENTIAL OF FINGOLIMOD IN NPC DISEASE

Morteza Abyadeh, Alaattin Kaya · 2024

Read MODULATING CELLULAR SENESCENCE AND MTOR PATHWAY: THE THERAPEUTIC POTENTIAL OF FINGOLIMOD IN NPC DISEASE by Morteza Abyadeh, Alaattin Kaya (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11692999.txt.

Description

Morteza Abyadeh and Alaattin Kaya test a known immune drug as a treatment for Niemann-Pick type C disease, in work from 2024. The disease is a genetic disorder that harms the brain, above all the cerebellum, and has no effective care. The drug is used for multiple sclerosis and may also guard nerve cells.

In cell and mouse tests, early drug treatment cut cell aging signs and slowed muscle loss. Treated mice also did better on balance and grip tests that gauge nerve and muscle function. Gene and protein checks pointed to a growth signal path and to swelling paths as routes of action. Gains ran stronger in male mice than in females, a split the authors flag for later work.

Catalog record

CREATORMorteza Abyadeh, Alaattin Kaya
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE1 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11692999

Browse the full library · About the Tower of Babel